Charles River Laboratories Intl (CRL) 84.08 $CRL
Charles River Laboratories Has Returned 37.8% Since SmarTrend Recommendation (CRL)
Comtex SmarTrend(R) - Thu Mar 19, 5:11PM CDT
SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on October 17th, 2014 at $61.11. In approximately 5 months, Charles River Laboratories has returned 37.78% as of today's recent price of $84.20.
CRL: 84.08 (-0.12)
After Yesterday's Rally of 2.75% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Mar 19, 5:07PM CDT
Charles River Laboratories (NYSE:CRL) traded in a range yesterday that spanned from a low of $81.93 to a high of $84.21. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $82.46 on volume of 613,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CRL: 84.08 (-0.12)
Oil Will Be Higher This Time Next Year - Cramer's Mad Money (3/18/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Mar 19, 6:16AM CDT
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, March 18. With the Fed meet over, it's time to focus on stocks, profitability and pent up demand for stocks. Cramer said that the U.S. is the strongest...
SBUX: 97.46 (-0.30), VEEV: 27.28 (-0.65), KO: 40.65 (+0.63), GPRO: 40.40 (+0.87), AXP: 82.70 (+1.16), TMO: 136.63 (+1.87), FB: 83.80 (+1.05), COST: 152.59 (+1.28), WFC: 56.01 (+0.50), CRL: 84.08 (-0.12), PLKI: 59.94 (-0.46), MMP: 78.94 (-0.74)
Jim Cramer's 'Mad Money' Recap: The Fed Does the Right Thing
at The Street - Wed Mar 18, 7:01PM CDT
The Federal Reserve is smarter than you think, Cramer says.
TSLA: 198.08 (+2.43), ZIOP: 13.89 (-0.11), AR: 36.03 (+0.40), DRNA: 24.81 (-1.69), AKAM: 72.87 (+0.12), FB: 83.80 (+1.05), WFC: 56.01 (+0.50), LBIO: 13.59 (-0.90), FIVE: 31.86 (+0.49), PLKI: 59.94 (-0.46), SBUX: 97.46 (-0.30), ESPR: 112.33 (+2.19), RCPT: 148.30 (-4.85), CRZO: 47.86 (+1.37), CRL: 84.08 (-0.12), MMP: 78.94 (-0.74), ROST: 107.46 (+0.72), REGN: 488.87 (+2.85)
Charles River Laboratories Up 31.3% Since SmarTrend Uptrend Call (CRL)
Comtex SmarTrend(R) - Thu Mar 12, 11:23AM CDT
SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on October 17th, 2014 at $61.11. In approximately 5 months, Charles River Laboratories has returned 31.29% as of today's recent price of $80.23.
CRL: 84.08 (-0.12)
Insider Trading Alert - CRL, IDA And WTS Traded By Insiders
at The Street - Fri Mar 06, 10:00AM CST
Stocks with insider trader activity include CRL, IDA and WTS
WTS: 55.53 (+0.59), IDA: 62.86 (+0.64), CRL: 84.08 (-0.12)
Charles River Laboratories to Present at March Investor Conferences
Business Wire - Mon Mar 02, 7:00AM CST
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including:
CRL: 84.08 (-0.12)
Insider Trading Alert - DATA, GM And CRL Traded By Insiders
at The Street - Thu Feb 19, 9:45AM CST
Stocks with insider trader activity include DATA, GM and CRL
GM: 38.87 (+0.22), CRL: 84.08 (-0.12), DATA: 93.96 (-3.49)
Charles River Laboratories Shares Up 22.1% Since SmarTrend's Buy Recommendation (CRL)
Comtex SmarTrend(R) - Wed Feb 18, 5:16PM CST
SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on October 17th, 2014 at $61.11. In approximately 4 months, Charles River Laboratories has returned 22.07% as of today's recent price of $74.60.
CRL: 84.08 (-0.12)
Insider Trading Alert - CCF, EPAM And CRL Traded By Insiders
at The Street - Wed Feb 18, 9:45AM CST
Stocks with insider trader activity include CCF, EPAM and CRL
CRL: 84.08 (-0.12), EPAM: 61.38 (-0.20), CCF: 42.97 (+0.06)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 42.12 (+0.59), ACHC: 72.77 (+1.17), FLEX: 12.28 (+0.16), GE: 25.40 (+0.07), BBT: 39.81 (+0.25), AWAY: 31.29 (+0.33), XOM: 84.54 (+0.13), KEY: 14.65 (+0.22), INTC: 31.31 (+0.57), AFFX: 12.87 (-0.07), TWX: 87.89 (+1.06), PEP: 95.34 (+1.24), AEP: 57.70 (+0.65), ETP: 56.26 (+1.25), CMG: 686.65 (+5.98), QLYS: 46.40 (-0.25), GOOGL: 564.95 (+1.28), MSFT: 42.88 (+0.60), HSIC: 143.01 (+2.32), AAPL: 125.90 (-1.60), REGN: 488.87 (+2.85), CSCO: 28.44 (+0.18), CY: 15.70 (+0.28), SWKS: 102.05 (+2.48), PWR: 28.04 (+0.22), FB: 83.80 (+1.05), PFE: 34.25 (+0.10), HAL: 42.82 (+1.27), AMGN: 170.10 (+0.99), BAC: 15.84 (+0.23), BMY: 67.76 (-0.56), BA: 154.50 (+0.39), HPQ: 33.28 (+0.44), RAD: 8.05 (-0.18), CELG: 128.50 (+3.17), ZTS: 47.34 (-0.07), UA: 81.43 (+0.42), AA: 12.97 (+0.01), GILD: 102.29 (+0.85), STI: 42.66 (+0.53), GM: 38.87 (+0.22), AGIO: 107.97 (-2.99), CRL: 84.08 (-0.12), FSL: 43.39 (+0.82), VIAB: 69.76 (+0.95), CL: 69.56 (+1.27)
Charles River Laboratories International's (CRL) CEO James Foster on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 11, 3:17PM CST
CRL: 84.08 (-0.12)
Charles River Laboratories to Present at Leerink Global Healthcare Conference
Business Wire - Wed Feb 11, 3:15PM CST
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Leerink Global Healthcare Conference in New York on Thursday, February 12th, at 10:20 a.m. EST. Management will present an overview of Charles River's strategic focus and business developments.
CRL: 84.08 (-0.12)
Shares of CRL Up 18.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 11, 11:17AM CST
SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on October 17th, 2014 at $61.11. In approximately 4 months, Charles River Laboratories has returned 18.85% as of today's recent price of $72.63.
CRL: 84.08 (-0.12)
Charles River Laboratories ups earnings 42% in Q4
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 9:41AM CST
CRL: 84.08 (-0.12)
Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:54AM CST
Charles River Laboratories (CRL) reported fourth-quarter 2014 earnings (excluding special items) of 81 cents per share, easily beating both the Zacks Consensus Estimate of 71 cents.
BIIB: 475.98 (+42.33), ABC: 113.46 (+1.09), MCK: 229.94 (+4.19), CRL: 84.08 (-0.12)
Charles River Laboratories beats by $0.09, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:35PM CST
CRL: 84.08 (-0.12)
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2014 Results from Continuing Operations and Provides 2015 Guidance
Business Wire - Tue Feb 10, 3:30PM CST
--- Fourth-Quarter GAAP Earnings per Share of $0.59 and Non-GAAP Earnings per Share of $0.81 -
CRL: 84.08 (-0.12)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 4:35PM CST
SGMO: 17.63 (-0.91), USNA: 108.53 (+5.51), RLOC: 2.93 (+0.07), ATEN: 4.45 (+0.17), VSAT: 61.04 (unch), RPXC: 15.01 (+0.43), TRMB: 25.92 (+0.73), KGC: 2.42 (+0.06), WSH: 49.17 (-0.02), TSRA: 43.54 (+0.86), FTI: 36.79 (+0.58), ACGL: 62.69 (+0.71), LOCK: 14.25 (+0.53), CERN: 73.73 (-0.09), CAP: 24.47 (+0.77), JIVE: 5.12 (+0.01), WU: 19.20 (-0.05), AKAM: 72.87 (+0.12), SKT: 36.29 (+0.39), NCR: 30.70 (+0.45), FRT: 149.44 (+3.04), SCI: 26.78 (+0.27), ELON: 1.12 (+0.02), GNW: 7.38 (+0.12), RKUS: 12.74 (+0.11), GHDX: 32.14 (-0.66), BLKB: 47.35 (+0.99), PXD: 163.56 (+4.82), SGEN: 38.86 (-0.83), OHI: 40.67 (+0.75), THOR: 40.14 (-0.40), MKTO: 26.27 (-0.30), CRL: 84.08 (-0.12), TMH: 59.25 (+0.66), ANDE: 42.76 (+3.14), XOOM: 14.90 (+0.03), HIW: 46.59 (+1.48), PAYC: 33.77 (-1.34)
Carl Subsidiary Hires Chief Technology Officer
Marketwired - Thu Feb 05, 8:03AM CST
Carl Capital Corp. ("Carl" or the "Corporation"
(CSE: CRL), a developer of proprietary software as a service ("SaaS"-based solutions for data integration and business intelligence, is pleased to announce that Carl's wholly owned subsidiary, Extend to Social Media Inc. ("ETS", has appointed Piotr Stepinski ("Piotr" as its Chief Technology Officer. Piotr is an accomplished systems engineer with interests in Microsoft BI stack and Sharepoint. His academic background includes a Master of Science degree in Electronics, Telecommunications and Informatics where he concentrated in GIS Systems and Knowledge Engineering. After an extensive career as a systems engineer for several companies, including Aetna, Telzas, Scandisoft and Infotech, Piotr began consulting with companies in countries around the world.
CRL: 84.08 (-0.12)
Charles River Laboratories Has Returned 37.8% Since SmarTrend Recommendation (CRL)
Comtex SmarTrend(R) - Thu Mar 19, 5:11PM CDT
SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on October 17th, 2014 at $61.11. In approximately 5 months, Charles River Laboratories has returned 37.78% as of today's recent price of $84.20.
CRL: 84.08 (-0.12)
After Yesterday's Rally of 2.75% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Mar 19, 5:07PM CDT
Charles River Laboratories (NYSE:CRL) traded in a range yesterday that spanned from a low of $81.93 to a high of $84.21. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $82.46 on volume of 613,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CRL: 84.08 (-0.12)
Oil Will Be Higher This Time Next Year - Cramer's Mad Money (3/18/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Mar 19, 6:16AM CDT
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, March 18. With the Fed meet over, it's time to focus on stocks, profitability and pent up demand for stocks. Cramer said that the U.S. is the strongest...
SBUX: 97.46 (-0.30), VEEV: 27.28 (-0.65), KO: 40.65 (+0.63), GPRO: 40.40 (+0.87), AXP: 82.70 (+1.16), TMO: 136.63 (+1.87), FB: 83.80 (+1.05), COST: 152.59 (+1.28), WFC: 56.01 (+0.50), CRL: 84.08 (-0.12), PLKI: 59.94 (-0.46), MMP: 78.94 (-0.74)
Jim Cramer's 'Mad Money' Recap: The Fed Does the Right Thing
at The Street - Wed Mar 18, 7:01PM CDT
The Federal Reserve is smarter than you think, Cramer says.
TSLA: 198.08 (+2.43), ZIOP: 13.89 (-0.11), AR: 36.03 (+0.40), DRNA: 24.81 (-1.69), AKAM: 72.87 (+0.12), FB: 83.80 (+1.05), WFC: 56.01 (+0.50), LBIO: 13.59 (-0.90), FIVE: 31.86 (+0.49), PLKI: 59.94 (-0.46), SBUX: 97.46 (-0.30), ESPR: 112.33 (+2.19), RCPT: 148.30 (-4.85), CRZO: 47.86 (+1.37), CRL: 84.08 (-0.12), MMP: 78.94 (-0.74), ROST: 107.46 (+0.72), REGN: 488.87 (+2.85)
Charles River Laboratories Up 31.3% Since SmarTrend Uptrend Call (CRL)
Comtex SmarTrend(R) - Thu Mar 12, 11:23AM CDT
SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on October 17th, 2014 at $61.11. In approximately 5 months, Charles River Laboratories has returned 31.29% as of today's recent price of $80.23.
CRL: 84.08 (-0.12)
Insider Trading Alert - CRL, IDA And WTS Traded By Insiders
at The Street - Fri Mar 06, 10:00AM CST
Stocks with insider trader activity include CRL, IDA and WTS
WTS: 55.53 (+0.59), IDA: 62.86 (+0.64), CRL: 84.08 (-0.12)
Charles River Laboratories to Present at March Investor Conferences
Business Wire - Mon Mar 02, 7:00AM CST
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including:
CRL: 84.08 (-0.12)
Insider Trading Alert - DATA, GM And CRL Traded By Insiders
at The Street - Thu Feb 19, 9:45AM CST
Stocks with insider trader activity include DATA, GM and CRL
GM: 38.87 (+0.22), CRL: 84.08 (-0.12), DATA: 93.96 (-3.49)
Charles River Laboratories Shares Up 22.1% Since SmarTrend's Buy Recommendation (CRL)
Comtex SmarTrend(R) - Wed Feb 18, 5:16PM CST
SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on October 17th, 2014 at $61.11. In approximately 4 months, Charles River Laboratories has returned 22.07% as of today's recent price of $74.60.
CRL: 84.08 (-0.12)
Insider Trading Alert - CCF, EPAM And CRL Traded By Insiders
at The Street - Wed Feb 18, 9:45AM CST
Stocks with insider trader activity include CCF, EPAM and CRL
CRL: 84.08 (-0.12), EPAM: 61.38 (-0.20), CCF: 42.97 (+0.06)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 42.12 (+0.59), ACHC: 72.77 (+1.17), FLEX: 12.28 (+0.16), GE: 25.40 (+0.07), BBT: 39.81 (+0.25), AWAY: 31.29 (+0.33), XOM: 84.54 (+0.13), KEY: 14.65 (+0.22), INTC: 31.31 (+0.57), AFFX: 12.87 (-0.07), TWX: 87.89 (+1.06), PEP: 95.34 (+1.24), AEP: 57.70 (+0.65), ETP: 56.26 (+1.25), CMG: 686.65 (+5.98), QLYS: 46.40 (-0.25), GOOGL: 564.95 (+1.28), MSFT: 42.88 (+0.60), HSIC: 143.01 (+2.32), AAPL: 125.90 (-1.60), REGN: 488.87 (+2.85), CSCO: 28.44 (+0.18), CY: 15.70 (+0.28), SWKS: 102.05 (+2.48), PWR: 28.04 (+0.22), FB: 83.80 (+1.05), PFE: 34.25 (+0.10), HAL: 42.82 (+1.27), AMGN: 170.10 (+0.99), BAC: 15.84 (+0.23), BMY: 67.76 (-0.56), BA: 154.50 (+0.39), HPQ: 33.28 (+0.44), RAD: 8.05 (-0.18), CELG: 128.50 (+3.17), ZTS: 47.34 (-0.07), UA: 81.43 (+0.42), AA: 12.97 (+0.01), GILD: 102.29 (+0.85), STI: 42.66 (+0.53), GM: 38.87 (+0.22), AGIO: 107.97 (-2.99), CRL: 84.08 (-0.12), FSL: 43.39 (+0.82), VIAB: 69.76 (+0.95), CL: 69.56 (+1.27)
Charles River Laboratories International's (CRL) CEO James Foster on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 11, 3:17PM CST
CRL: 84.08 (-0.12)
Charles River Laboratories to Present at Leerink Global Healthcare Conference
Business Wire - Wed Feb 11, 3:15PM CST
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Leerink Global Healthcare Conference in New York on Thursday, February 12th, at 10:20 a.m. EST. Management will present an overview of Charles River's strategic focus and business developments.
CRL: 84.08 (-0.12)
Shares of CRL Up 18.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 11, 11:17AM CST
SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on October 17th, 2014 at $61.11. In approximately 4 months, Charles River Laboratories has returned 18.85% as of today's recent price of $72.63.
CRL: 84.08 (-0.12)
Charles River Laboratories ups earnings 42% in Q4
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 9:41AM CST
CRL: 84.08 (-0.12)
Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:54AM CST
Charles River Laboratories (CRL) reported fourth-quarter 2014 earnings (excluding special items) of 81 cents per share, easily beating both the Zacks Consensus Estimate of 71 cents.
BIIB: 475.98 (+42.33), ABC: 113.46 (+1.09), MCK: 229.94 (+4.19), CRL: 84.08 (-0.12)
Charles River Laboratories beats by $0.09, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:35PM CST
CRL: 84.08 (-0.12)
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2014 Results from Continuing Operations and Provides 2015 Guidance
Business Wire - Tue Feb 10, 3:30PM CST
--- Fourth-Quarter GAAP Earnings per Share of $0.59 and Non-GAAP Earnings per Share of $0.81 -
CRL: 84.08 (-0.12)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 4:35PM CST
SGMO: 17.63 (-0.91), USNA: 108.53 (+5.51), RLOC: 2.93 (+0.07), ATEN: 4.45 (+0.17), VSAT: 61.04 (unch), RPXC: 15.01 (+0.43), TRMB: 25.92 (+0.73), KGC: 2.42 (+0.06), WSH: 49.17 (-0.02), TSRA: 43.54 (+0.86), FTI: 36.79 (+0.58), ACGL: 62.69 (+0.71), LOCK: 14.25 (+0.53), CERN: 73.73 (-0.09), CAP: 24.47 (+0.77), JIVE: 5.12 (+0.01), WU: 19.20 (-0.05), AKAM: 72.87 (+0.12), SKT: 36.29 (+0.39), NCR: 30.70 (+0.45), FRT: 149.44 (+3.04), SCI: 26.78 (+0.27), ELON: 1.12 (+0.02), GNW: 7.38 (+0.12), RKUS: 12.74 (+0.11), GHDX: 32.14 (-0.66), BLKB: 47.35 (+0.99), PXD: 163.56 (+4.82), SGEN: 38.86 (-0.83), OHI: 40.67 (+0.75), THOR: 40.14 (-0.40), MKTO: 26.27 (-0.30), CRL: 84.08 (-0.12), TMH: 59.25 (+0.66), ANDE: 42.76 (+3.14), XOOM: 14.90 (+0.03), HIW: 46.59 (+1.48), PAYC: 33.77 (-1.34)
Carl Subsidiary Hires Chief Technology Officer
Marketwired - Thu Feb 05, 8:03AM CST
Carl Capital Corp. ("Carl" or the "Corporation"
(CSE: CRL), a developer of proprietary software as a service ("SaaS"-based solutions for data integration and business intelligence, is pleased to announce that Carl's wholly owned subsidiary, Extend to Social Media Inc. ("ETS", has appointed Piotr Stepinski ("Piotr" as its Chief Technology Officer. Piotr is an accomplished systems engineer with interests in Microsoft BI stack and Sharepoint. His academic background includes a Master of Science degree in Electronics, Telecommunications and Informatics where he concentrated in GIS Systems and Knowledge Engineering. After an extensive career as a systems engineer for several companies, including Aetna, Telzas, Scandisoft and Infotech, Piotr began consulting with companies in countries around the world. CRL: 84.08 (-0.12)
